Azathioprine in controlling type 2 reactions in leprosy: a case report.
Athreya
S P K
SP
The Leprosy Mission Hospital, Nand Nagari, Delhi, India. tlmshahdara@tlm-india.org
D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004893:Erythema Nodosum / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015440:Leprosy, Lepromatous / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged
D007166:Immunosuppressive Agents; D007917:Leprostatic Agents; D001379:Azathioprine